Dacomitinib
ATC L01EB07 · 9 markets · 23 records
US 3 records · 3 strengths
GB 3 records · 3 strengths
SG 3 records · 3 strengths
TW 3 records · 3 strengths
HK 3 records · 1 strengths
Records without a stated strength · 1 Vizimpro
ES 2 records · 2 strengths
MX 1 records · 1 strengths
Records without a stated strength · 1 Vizimpro
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Vizimpro
| Strength / form / release | US | GB | SG | ES | MX | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|
| 30 mg tablet | Vizimpro | Vizimpro | Vizimpro | Vizimpro | Vizimpro 肺欣妥膜衣錠30毫克 | |||
| 15 mg tablet | Vizimpro | Vizimpro | Vizimpro | Vizimpro | Vizimpro 肺欣妥膜衣錠15毫克 | |||
| 45 mg tablet | Vizimpro | Vizimpro | Vizimpro | Vizimpro 肺欣妥膜衣錠45毫克 | ||||
unknown | Vizimpro | Vizimpro | ||||||
tablet | Vizimpro |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
2 more strength/form rows are recorded only in MX · HK · EU and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en MX · HK · EU que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 MX · HK · EU 有记录(未在本表显示)。 另有 2 個規格/劑型僅在 MX · HK · EU 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.